Posted by Michael Wonder on 15 Apr 2025
ICER releases draft evidence report on treatment for secondary progressive multiple sclerosis
15 April 2025 - Public comment period now open until 13 May 2025; Requests to make oral comment during public meeting also being accepted.
The ICER today released a draft evidence report assessing the comparative clinical effectiveness and value of tolebrutinib (Sanofi) for the treatment of secondary progressive multiple sclerosis.
